Connect with us
Information
About Us
Contact Us
Careers
Partnerships
Advertise With Us
Authors
Browse Topics
Events
Disclaimer
Privacy Policy
Australia
North America
World
Login
Investing News
Network
Your trusted source for investing success
North America
Australia
World
My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
Reports & Guides
Market Outlook Reports
Investing Guides
Button
Resource
Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals
Tech
Life Science
nasdaq:tyme
POPULAR ARTICLES
TYME Launches TYME-88-PANC Trial
5 Top Weekly NASDAQ Biotech & Pharma Stocks: Corvus Soars
TYME Provides Updated Data on TYME-88-Panc Phase II Study
LATEST ARTICLES
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
TYME Receives FDA Guidance on Pivotal Trial for SM-88 in Treatment for Advanced Pancreatic Cancer
TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study
Tyme Exceeds Enrollment Expectations for the Phase II Trial of SM-88 in Pancreatic Cancer
Tyme Technologies Provides Clinical and Corporate Update for Fiscal 1Q 2019
Latest News
Over 50% Q-o-Q Production Growth Targeted
Analyst Report: Locksley’s US Strategy Strengthens Critical Minerals Position
Altech Batteries Ltd Annual Report to Shareholders
Alvopetro Announces Q3 2025 Dividend of US$0.10 Per Share
Prince Silver: Advancing the Large-scale Prince Silver Project in Nevada
More News
Outlook Reports
Resource
Precious Metals
Gold
Silver
Battery Metals
Lithium
Cobalt
Graphite
Energy
Uranium
Oil and Gas
Base Metals
Copper
Nickel
Zinc
Critical Metals
Rare Earths
Industrial Metals
Agriculture
Tech
Artificial Intelligence
Cybersecurity
Gaming
Cleantech
Emerging Tech
Life Science
Biotech
Cannabis
Psychedelics
Pharmaceuticals
Featured Stocks
Angkor Resources
Prince Silver
Cardiol Therapeutics
Red Sky Energy
Iris Metals
Fortuna Metals
More featured stocks
Browse Companies
Resource
Precious Metals
Battery Metals
Energy
Base Metals
Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES